Viewing Study NCT02722733


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-02-26 @ 4:16 PM
Study NCT ID: NCT02722733
Status: UNKNOWN
Last Update Posted: 2016-03-30
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HL/NHLMobil-COI-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators